[58mCo]Co-DOTA-PSMA-617: A novel radioligand for Auger electron therapy of prostate cancer

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerP 167
TidsskriftJournal of Labelled Compounds and Radiopharmaceuticals
Vol/bind60
Udgave nummerSuppl. 1
Sider (fra-til)S327
Antal sider1
ISSN0362-4803
DOI
StatusUdgivet - maj 2017
Begivenhed22nd International Symposium on Radiopharmaceutical Sciences - International Congress Center, Dresden, Tyskland
Varighed: 14. maj 201719. maj 2017

Konference

Konference22nd International Symposium on Radiopharmaceutical Sciences
LokationInternational Congress Center
LandTyskland
ByDresden
Periode14/05/201719/05/2017

Citer dette

@article{681a770f9098490b84a7cb938d13e41e,
title = "[58mCo]Co-DOTA-PSMA-617: A novel radioligand for Auger electron therapy of prostate cancer",
author = "Helge Thisgaard and Olsen, {Birgitte Brinkmann} and Christina Baun and Dam, {Johan Hygum}",
year = "2017",
month = "5",
doi = "10.1002/jlcr.3508",
language = "English",
volume = "60",
pages = "S327",
journal = "Journal of Labelled Compounds and Radiopharmaceuticals",
issn = "0362-4803",
publisher = "JohnWiley & Sons Ltd.",
number = "Suppl. 1",

}

[58mCo]Co-DOTA-PSMA-617: A novel radioligand for Auger electron therapy of prostate cancer. / Thisgaard, Helge; Olsen, Birgitte Brinkmann; Baun, Christina; Dam, Johan Hygum.

I: Journal of Labelled Compounds and Radiopharmaceuticals, Bind 60, Nr. Suppl. 1, P 167, 05.2017, s. S327.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - [58mCo]Co-DOTA-PSMA-617: A novel radioligand for Auger electron therapy of prostate cancer

AU - Thisgaard, Helge

AU - Olsen, Birgitte Brinkmann

AU - Baun, Christina

AU - Dam, Johan Hygum

PY - 2017/5

Y1 - 2017/5

U2 - 10.1002/jlcr.3508

DO - 10.1002/jlcr.3508

M3 - Conference abstract in journal

C2 - 28502124

VL - 60

SP - S327

JO - Journal of Labelled Compounds and Radiopharmaceuticals

JF - Journal of Labelled Compounds and Radiopharmaceuticals

SN - 0362-4803

IS - Suppl. 1

M1 - P 167

ER -